Disc Medicine

IPO

Harnessing Breakthrough Science to Advance Hematology Care

Public · Watertown, United States · Founded 2021 · $222.5M raised

Employees
51–200
Founded
2021
Business Model
B2B
Total Funding
$222.5M
Last Round
$20.0M Series DFeb 2026
Rounds
4
Type
Public

About

Disc Medicine is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for hematologic diseases. The company applies new insights in heme biosynthesis and iron metabolism to develop first-in-class therapies, including bitopertin for erythropoietic protoporphyria and DISC-0974 for myelofibrosis-associated anemia. Disc Medicine is listed on Nasdaq under the ticker IRON.

Summary

Disc Medicine is a Biotech company based in Watertown, United States, founded in 2021. It has raised $222.5M in total across 4 rounds, most recently a $20.0M Series D round in Feb 2026. Investors include Bain Capital Life Sciences, OrbiMed and Atlas Venture.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series DSeries DFeb 2026
$20.0M

Sign up to see all 4 rounds

Series A through Series D — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Disc Medicine on Indexed.vc
<a href="https://indexed.vc/companies/disc-medicine"><img src="https://indexed.vc/api/badge/company/disc-medicine" alt="Disc Medicine on Indexed.vc" width="260" height="76" /></a>